ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?
Problem of anticoagulant choice in patients with acute coronary syndrome (ACS) is discussed. Results of the main trials on low-molecular heparin therapy in patients with ACS as well as recommendations of European cardiology society and American heart association are presented. Peculiarities of other...
Saved in:
| Main Authors: | A. L. Komarov, E. P. Panchenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1095 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of anticoagulants in the treatment of community-acquired pneumonia in patients combined with coronavirus infection
by: I. M. Fushtei, et al.
Published: (2025-02-01) -
Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue
by: O. D. Ostroumova, et al.
Published: (2020-07-01) -
Anticoagulation Management Post Pulmonary Embolism
by: Joseph J. Naoum
Published: (2024-05-01) -
Optimising the treatment of patients with acute coronary syndrome without ST segment elevation
by: T. M. Poponina, et al.
Published: (1970-01-01) -
Osteoporosis and antithrombotic therapy
by: N. V. Brailova, et al.
Published: (2021-06-01)